Ontology highlight
ABSTRACT: Background
Patients with intermediate-risk pulmonary embolism (PE) can be treated with anticoagulation monotherapy. However, clinicians are concerned as to whether anticoagulation monotherapy is sufficient to reduce mortality in patients with a large embolic burden, and to resolve vascular obstruction. We investigated whether anticoagulation monotherapy was appropriate in patients with intermediate risk PE in terms of the occurrence of residual pulmonary vascular obstruction (RPVO), and the factors that independently predict the occurrence of RPVO.Methods
This was a multicenter retrospective observational study of patients at intermediate risk of PE who were admitted to three hospitals between January 2012 and December 2017.Results
Of total 91 patients, the median a
SUBMITTER: Chang Y
PROVIDER: S-EPMC8339779 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature